Total-body irradiation - Role and indications: Results from the German Registry for Stem Cell Transplantation (DRST)

Strahlentherapie und Onkologie

Volumn 182, Issue 4, 2006, Pages 222-230

  Heinzelmann, Frank ^a   Ottinger, Helmut ^b   Müller, Carl Heinz ^c   Allgaier, Sandra ^c   Faul, Christoph ^a   Bamberg, Michael ^a   Belka, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c DRST Datacenter   (Germany)

Author keywords

Autologous allogeneic transplantation; Conditioning process; Stem cell source; Total body irradiation (TBI); Treatment center size; Type of donor

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER RADIOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL OBSERVATION; CONTROLLED STUDY; DONOR; GERMANY; HEALTH CENTER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MORBIDITY; NONHODGKIN LYMPHOMA; PATIENT ASSESSMENT; REGISTER; TREATMENT INDICATION; WHOLE BODY RADIATION;

ACUTE DISEASE; GERMANY; HISTOCOMPATIBILITY TESTING; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; LYMPHOMA, NON-HODGKIN; REGISTRIES; STEM CELL TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 33645864673     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1468-1     Document Type: Article

References (35)

1. Barrett A. Total body irradiation before bone marrow transplantation: a review. Clin Radiol 1982;33:131-5.
2. Bastion Y, Brice P, Haioun C, et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood 1995;86:3257-62.
3. Belka C, Schmid B, Marini P, et al. Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL. Oncogene 2001;20:2190-6.
4. Belkacemi Y, Pene F, Touboul E, et al. Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients. Strahlenther Onkol 1998;174:92-104.
5. Blaise D, Maraninchi D, Archimbaud E, et al. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse. Blood 1992;79:2578-82.
6. Blaise D, Maraninchi D, Michallet M, et al. Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission. Blood 2001;97:3669-71.
7. Clift RA, Buckner CD, Thomas ED, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994;84:2036-43.
8. Clift RA, Radich J, Appelbaum FR, et al. Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemia. Blood 1999;94:3960-2.
9. Colombat P, Donadio D, Fouillard L, et al. Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. Bone Marrow Transplant 1994;13:157-62.
10. Cosset JM, Socie G, Girinsky T, et al. Radiobiological and clinical bases for total body irradiation in the leukemias and lymphomas. Semin Radiat Oncol 1995;5:301-5.
11. Davies SM, Ramsay NK, Klein JP, et al. Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol 2000;18:340-7.
12. Deeg HJ, Shulman HM, Anderson JE, et al. Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age. Blood 2000;95:1188-94.
13. Devergie A, Blaise D, Attal M, et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (SFGM). Blood 1995;85:2263-8.
14. Fujimaki K, Taguchi J, Fujita H, et al. Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. Bone Marrow Transplant 2004;33:789-92.
15. Granados E, de La Camara R, Madero L, et al. Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation. Haematologica 2000;85:1060-7.
16. Igaki H, Karasawa K, Sakamaki H, et al. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks. Strahlenther Onkol 2005;181:704-8.
17. Janicke RU, Engels IH, Dunkern, T et al. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Oncogene 2001;20:5043-53.
18. Jurado M, Deeg HJ, Storer B, et al. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality. Biol Blood Marrow Transplant 2002;8:161-9.
19. Krause M, Prager J, Wohlfarth J, et al. Ultrafractionation does not improve the results of radiotherapy in radioresistant murine DDL1 lymphoma. Strahlenther Onkol 2005;181:540-4.
20. Litzow MR, Perez WS, Klein JP, et al. Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. Br J Haematol 2002;119:1115-24.
21. 2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial. Blood 2002;99:731-5.
22. Muller RP, Eich HT. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel. Strahlenther Onkol 2005;181:557-66.
23. Ott OJ, Rodel C, Gramatzki M, et al. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma. Strahlenther Onkol 2003;179:694-701.
24. Ringden O, Remberger M, Ruutu T, et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. Blood 1999;93:2196-201.
25. Ringden O, Ruutu T, Remberger M, et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 1994;83:2723-30.
26. Sakata KI, Satoh M, Someya M, et al. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification. Strahlenther Onkol 2005;181:385-91.
27. Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983;309:1347-53.
28. Schouten HC, Colombat P, Verdonck LF, et al. Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for Lymphoma. Ann Oncol 1994;5:Suppl 2:147-9.
29. Socie G, Clift RA, Blaise D, et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001;98:3569-74.
30. Thomas ED, Epstein RB. Bone marrow transplantation in acute Leukemia. Cancer Res 1965;25:1521-4.
31. Tutschka PJ, Copelan EA, Kapoor N, et al. Allogeneic bone marrow transplantation for leukemia using chemotherapy as conditioning: 6-year results of a single institution trial. Transplant Proc 1991;23:1709-10.
32. Van Besien K, Keralavarma B, Devine S, et al. Allogeneic and autologous transplantation for chronic lymphocytic leukemia. Leukemia 2001;15:1317-25.
33. Wachowiak J, Bettoni C, Lange A, et al. Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia? Acta Haematol Pol 1995;26:377-84.
34. Wheldon TE. The radiobiological basis of total body irradiation. Br J Radiol 1997;70:1204-7.
35. Wheldon TE, Barrett A. Radiobiological modelling of the treatment of leukaemia by total body irradiation. Radiother Oncol 2001;58:227-33.